Bank of New York Mellon’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $1.4M | Sell |
|
|||||
|
2023
Q4 | $1.34M | Buy |
|
|||||
|
2023
Q3 | $1.23M | Sell |
|
|||||
|
2023
Q2 | $1.23M | Buy |
|
|||||
|
2023
Q1 | $920K | Hold |
|
|||||
|
2022
Q4 | $858K | Buy |
|
|||||
|
2022
Q3 | $153K | Hold |
|
|||||
|
2022
Q2 | $244K | Sell |
|
|||||
|
2022
Q1 | $259K | Hold |
|
|||||
|
2021
Q4 | $160K | Hold |
|
|||||
|
2021
Q3 | $198K | Hold |
|
|||||
|
2021
Q2 | $262K | Sell |
|
|||||
|
2021
Q1 | $265K | Buy |
|
|||||
|
2020
Q4 | $121K | Buy |
|
|||||
|
2020
Q3 | $70K | Hold |
|
|||||
|
2020
Q2 | $58K | Buy |
|
|||||
|
2020
Q1 | $38K | Sell |
|
|||||
|
2019
Q4 | $56K | Hold |
|
|||||
|
2019
Q3 | $79K | Sell |
|
|||||
|
2019
Q2 | $107K | Hold |
|
|||||
|
2019
Q1 | $123K | Sell |
|
|||||
|
2018
Q4 | $70K | Buy |
|
|||||
|
2018
Q3 | – | Sell |
|
|||||
|
2018
Q2 | $211K | Sell |
|
|||||
|
2018
Q1 | $639K | Sell |
|
|||||
|
2017
Q4 | $822K | Buy |
|
|||||
|
2017
Q3 | $1M | Sell |
|
|||||
|
2017
Q2 | $876K | Sell |
|
|||||
|
2017
Q1 | $2.24M | Buy |
|
|||||
|
2016
Q4 | $2.92M | Buy |
|
|||||
|
2016
Q3 | $4.18M | Sell |
|
|||||
|
2016
Q2 | $3.65M | Buy |
|
|||||
|
2016
Q1 | $5.53M | Buy |
|
|||||
|
2015
Q4 | $5.15M | Buy |
|
|||||
|
2015
Q3 | $5.46M | Sell |
|
|||||
|
2015
Q2 | $10M | Buy |
|
|||||
|
2015
Q1 | $9.06M | Sell |
|
|||||
|
2014
Q4 | $8.64M | Sell |
|
|||||
|
2014
Q3 | $6.79M | Sell |
|
|||||
|
2014
Q2 | $5.82M | Sell |
|
|||||
|
2014
Q1 | $5.3M | Buy |
|
|||||
|
2013
Q4 | $5.51M | Buy |
|
|||||
|
2013
Q3 | $3.85M | Sell |
|
|||||
|
2013
Q2 | $7.02M | Buy |
|